TTN regulates abnormal cGAS-STING signalling pathway activation by modulating the interaction between STING and IRF3, demonstrating significant therapeutic potential for autoimmune diseases and ALI mediated by the cGAS-STING pathway. Here, STING1 is linked to autoimmune disease.